SEC Form 4 · accession 0001144204-18-048542
Semler Scientific, Inc. · SMLR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel E Conger
Officer — Vice President, Finance
Period of report
Sep 6, 2018
Accepted (ET)
Sep 7, 2018 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001554859
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 6, 2018 | M | 5,000 | $2.59 | A | 5,000 | D | |
| Common StockF1 | Sep 6, 2018 | S | 5,000 | $25.78 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $2.59 | Sep 6, 2018 | M | 5,000 | D | — | Dec 31, 2025 | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1The price reported is a weighted average price. The shares were sold at prices ranging from $25.50 to $26.00. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F2These options were granted pursuant to the Issuer's 2014 Stock Incentive Plan and are subject to monthly vesting over four years (1/48 per month) such that they will be vested in full on the four-year anniversary of the December 31, 2015 grant date.